Cargando…

Advent of CRISPR Based Immunotherapy in Hematologic Malignancies

Detalles Bibliográficos
Autores principales:	Perez, RK, Chen, R, Kang, R, Perez, AR
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018007/ https://www.ncbi.nlm.nih.gov/pubmed/29953127

Ejemplares similares

Immunotherapy in cervical cancer: the advent of precision medicine
por: De Felice, Francesca, et al.
Publicado: (2020)

Advent of Elkosin
por: Banerji, Binoy
Publicado: (1950)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020)

NK Cell-Based Immunotherapy for Hematological Malignancies
por: Sivori, Simona, et al.
Publicado: (2019)

The Advent of Old Age
Publicado: (1873)

The Advent of Lifestyle Medicine
por: Yeh, Byung-Il, et al.
Publicado: (2013)

Cellular immunotherapy for refractory hematological malignancies
por: Reagan, John L, et al.
Publicado: (2013)

Therapeutic Advances in Immunotherapies for Hematological Malignancies
por: Nogami, Ayako, et al.
Publicado: (2022)

Editorial: Immunotherapy for hematological malignancies in children
por: Zhou, Yusi, et al.
Publicado: (2023)

The adventive flora of Tweedside
por: Hayward, Ida M.
Publicado: (1919)

The Advent of Colloidal Alkaloids
Publicado: (1917)

Second Advent of Thomsonism
Publicado: (1848)

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies
por: Ye, Baixin, et al.
Publicado: (2017)

T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies
por: Tang, Lu, et al.
Publicado: (2021)

The landscape overview of CD47-based immunotherapy for hematological malignancies
por: Yang, Hua, et al.
Publicado: (2023)

Immunotherapy in hematologic malignancies: past, present, and future
por: Im, Annie, et al.
Publicado: (2017)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019)

Applying CRISPR-Cas9 screens to dissect hematological malignancies
por: Iyer, Deepak Narayanan, et al.
Publicado: (2022)

The advent of precision epigenetics for medulloblastoma
por: Li, Chaoxi, et al.
Publicado: (2020)

The young Einstein: the advent of relativity
por: Pyenson, Lewis
Publicado: (1985)

Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
por: Tang, Lu, et al.
Publicado: (2023)

Cellular immunotherapy as a beacon of hope for hematological malignancies
por: Lee, Hyun-Ju, et al.
Publicado: (2015)

Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
por: Noh, Ji-Yoon, et al.
Publicado: (2020)

Advent of Continents: A New Hypothesis
por: Tamura, Yoshihiko, et al.
Publicado: (2016)

Understanding the advent of artificial intelligence in ophthalmology
por: Ahuja, Abhimanyu S., et al.
Publicado: (2019)

Advent of extreme events in predator populations
por: Chaurasia, Sudhanshu Shekhar, et al.
Publicado: (2020)

Computational Oncology
por: Perez, RK, et al.
Publicado: (2018)

Advent of digital radiography: Part 1
por: Verma, BS, et al.
Publicado: (2008)

Advents in the Diagnosis and Management of Ischemic Colitis
por: Misiakos, Evangelos P., et al.
Publicado: (2017)

Advent of tirzepatide: boon for diabetic and obese?
por: Bhusal, Amrit
Publicado: (2023)

The advent of the algorithm: the idea that rules the world
por: Berlinski, David
Publicado: (2000)

Immunotherapy approaches for hematological cancers
por: Lanier, Olivia L., et al.
Publicado: (2022)

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
por: Janelle, Valérie, et al.
Publicado: (2020)

Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
por: Allegra, Alessandro, et al.
Publicado: (2021)

Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
por: Xu, Zhengli, et al.
Publicado: (2021)

Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies
por: Tapia-Galisteo, Antonio, et al.
Publicado: (2023)

The advent of ECMO and pumpless extracorporeal lung assist in ARDS
por: Hamid, I A, et al.
Publicado: (2011)

TIGIT: A promising target to overcome the barrier of immunotherapy in hematological malignancies
por: Jin, Shenhe, et al.
Publicado: (2022)

The Advent of Modern Medicine in Philadelphia, 1800-1850
por: Shryock, Richard H.
Publicado: (1941)

Diagnosis of viral disease and the advent of antiviral drugs
por: Herrmann, Ernest C., et al.
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_obcap0i3qdvim1jr5dib7uot55